Talquetamab–Daratumumab in Relapsed or Refractory Myeloma

Journal:

The New England Journal of Medicine

Published:

2026-06-14

DOI:

10.1056/nejmoa2604657

Affiliations:

63

Authors:

58

Go to article

Institutions	Authors	Share
Johnson & Johnson, United States of America (USA)	12.000000 12.000000	0.21
Johnson & Johnson Medical (China) Ltd., China	2.000000	0.03
Ankara University, Turkey	1.500000	0.03
Hospital de la Santa Creu i Sant Pau, Spain	1.000000	0.02
National Taiwan University Hospital (NTUH), Taiwan	1.000000	0.02
Fred Hutchinson Cancer Center, United States of America (USA)	1.000000	0.02
University of Bologna (UNIBO), Italy	1.000000	0.02
Shanghai Fourth People's Hospital, Tongji University, China	1.000000	0.02
Tel Aviv University (TAU), Israel	1.000000	0.02
Hospital Erasto Gaertner, Brazil	1.000000	0.02
The University of Osaka (UOsaka), Japan	1.000000	0.02
Cancer Institute Hospital, JFCR, Japan	1.000000	0.02
Medical University of Silesia (SUM), Poland	1.000000	0.02
Johnson & Johnson, Netherlands, Netherlands	1.000000	0.02
Medical University of Gdańsk (MUG), Poland	1.000000	0.02
Michigan Medicine, U-M, United States of America (USA)	1.000000	0.02
University Hospital Ostrava, OSU, Czech Republic	1.000000	0.02
Seoul St. Mary's Hospital, South Korea	1.000000	0.02
National Center for Tumor Diseases (NCT) Heidelberg, Germany	1.000000	0.02
Clínica São Germano, Brazil	1.000000	0.02
Peking Union Medical College Hospital (PUMCH), China	1.000000	0.02
University of Minnesota (UMN), United States of America (USA)	1.000000	0.02
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.02
Novant Health, United States of America (USA)	1.000000	0.02
Beijing Chaoyang Hospital, Capital Medical University, China	1.000000	0.02
Clínica Universidad de Navarra (CUN), UNAV, Spain	1.000000	0.02
Medipol University Hospital, Turkey	1.000000	0.02
University Hospital of Würzburg (UKW), JMU, Germany	1.000000	0.02
Ondokuz Mayis University (OMU), Turkey	1.000000	0.02
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.02
Holy Cross Cancer Center (SCO Kielce), Poland	1.000000	0.02
Seoul National University Hospital (SNUH), South Korea	1.000000	0.02
A.C. Camargo Cancer Center (CIPE), Brazil	1.000000	0.02
Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, China	1.000000	0.02
University Hospital Nantes (CHU de Nantes), France	1.000000	0.02
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France	0.666667	0.01
Instituto de Investigación Hospital 12 de Octubre (i+12), Spain	0.666667	0.01
Chaim Sheba Medical Center at Tel HaShomer, Israel	0.500000	0.01
Tel Aviv Sourasky Medical Center, Israel	0.500000	0.01
Korea University, South Korea	0.500000	0.01
The Royal Marsden NHS Foundation Trust, United Kingdom (UK)	0.500000	0.01
Wake Forest University (WFU), United States of America (USA)	0.500000	0.01
Levine Cancer Institute, Atrium Health, United States of America (USA)	0.500000	0.01
University of Turin (UNITO), Italy	0.500000	0.01
University Hospital Hradec Králové, Czech Republic	0.500000	0.01
Charles University (CU), Czech Republic	0.500000	0.01
National and Kapodistrian University of Athens (UOA), Greece	0.500000	0.01
The Institute of Cancer Research (ICR), United Kingdom (UK)	0.500000	0.01
Istinye University (ISU), Turkey	0.500000	0.01
Institute of Biomedical Research of Salamanca (IBSAL), Spain	0.333333	0.01
Institute of Molecular and Cell Biology of Cancer (IBMCC), Spain	0.333333	0.01
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain	0.333333	0.01
Josep Carreras Leukaemia Research Institute (IJC), Spain	0.333333	0.01
Catalan Institute of Oncology (ICO), Spain	0.333333	0.01
Germans Trias i Pujol University Hospital (HUGTP), ICS, Spain	0.333333	0.01
Université de Toulouse, France	0.333333	0.01
Spanish National Cancer Research Centre (CNIO), Spain	0.333333	0.01
The Winship Cancer Institute of Emory University, United States of America (USA)	0.250000	0.00
A.O.U. Citta della Salute e della Scienza di Torino, Italy	0.250000	0.00